nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Infestation—Tretinoin—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Vildagliptin—Infestation—Isotretinoin—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Vildagliptin—Liver function test abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00576	0.00576	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Topotecan—peripheral nervous system neoplasm	0.00561	0.00561	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Melphalan—peripheral nervous system neoplasm	0.00549	0.00549	CcSEcCtD
Vildagliptin—Hepatitis—Tretinoin—peripheral nervous system neoplasm	0.00528	0.00528	CcSEcCtD
Vildagliptin—Hepatitis—Isotretinoin—peripheral nervous system neoplasm	0.00528	0.00528	CcSEcCtD
Vildagliptin—Hepatitis—Melphalan—peripheral nervous system neoplasm	0.00521	0.00521	CcSEcCtD
Vildagliptin—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Vildagliptin—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Vildagliptin—Nasopharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00517	0.00517	CcSEcCtD
Vildagliptin—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Vildagliptin—Pancreatitis—Alitretinoin—peripheral nervous system neoplasm	0.0049	0.0049	CcSEcCtD
Vildagliptin—Blister—Epirubicin—peripheral nervous system neoplasm	0.00484	0.00484	CcSEcCtD
Vildagliptin—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.00483	0.00483	CcSEcCtD
Vildagliptin—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Vildagliptin—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Vildagliptin—Chills—Topotecan—peripheral nervous system neoplasm	0.00478	0.00478	CcSEcCtD
Vildagliptin—Chills—Tretinoin—peripheral nervous system neoplasm	0.00474	0.00474	CcSEcCtD
Vildagliptin—Chills—Isotretinoin—peripheral nervous system neoplasm	0.00474	0.00474	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00465	0.00465	CcSEcCtD
Vildagliptin—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.00464	0.00464	CcSEcCtD
Vildagliptin—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.0046	0.0046	CcSEcCtD
Vildagliptin—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.0046	0.0046	CcSEcCtD
Vildagliptin—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.00455	0.00455	CcSEcCtD
Vildagliptin—Flatulence—Tretinoin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Vildagliptin—Flatulence—Isotretinoin—peripheral nervous system neoplasm	0.00453	0.00453	CcSEcCtD
Vildagliptin—Blister—Doxorubicin—peripheral nervous system neoplasm	0.00448	0.00448	CcSEcCtD
Vildagliptin—Infestation NOS—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00446	CcSEcCtD
Vildagliptin—Infestation—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00446	CcSEcCtD
Vildagliptin—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.00441	0.00441	CcSEcCtD
Vildagliptin—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00432	0.00432	CcSEcCtD
Vildagliptin—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Vildagliptin—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Vildagliptin—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00424	0.00424	CcSEcCtD
Vildagliptin—Pancreatitis—Cisplatin—peripheral nervous system neoplasm	0.00418	0.00418	CcSEcCtD
Vildagliptin—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Vildagliptin—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00395	0.00395	CcSEcCtD
Vildagliptin—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00392	0.00392	CcSEcCtD
Vildagliptin—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Vildagliptin—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00389	0.00389	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00389	0.00389	CcSEcCtD
Vildagliptin—Chills—Dactinomycin—peripheral nervous system neoplasm	0.00387	0.00387	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00384	0.00384	CcSEcCtD
Vildagliptin—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.00379	0.00379	CcSEcCtD
Vildagliptin—Infection—Topotecan—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Vildagliptin—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Vildagliptin—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Vildagliptin—Infection—Tretinoin—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Vildagliptin—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Vildagliptin—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Vildagliptin—Oedema—Melphalan—peripheral nervous system neoplasm	0.0037	0.0037	CcSEcCtD
Vildagliptin—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Vildagliptin—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Vildagliptin—Infection—Melphalan—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Vildagliptin—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Vildagliptin—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Vildagliptin—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00365	0.00365	CcSEcCtD
Vildagliptin—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00365	0.00365	CcSEcCtD
Vildagliptin—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Vildagliptin—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Vildagliptin—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00363	0.00363	CcSEcCtD
Vildagliptin—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.0036	0.0036	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Vildagliptin—Chills—Alitretinoin—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Vildagliptin—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.0035	0.0035	CcSEcCtD
Vildagliptin—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Vildagliptin—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Vildagliptin—Infestation—Etoposide—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Vildagliptin—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Vildagliptin—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.00335	0.00335	CcSEcCtD
Vildagliptin—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Vildagliptin—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Vildagliptin—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00326	0.00326	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Vildagliptin—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Vildagliptin—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Vildagliptin—Constipation—Topotecan—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Vildagliptin—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Vildagliptin—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Vildagliptin—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Vildagliptin—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Vildagliptin—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00307	0.00307	CcSEcCtD
Vildagliptin—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Vildagliptin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Vildagliptin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Vildagliptin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Vildagliptin—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Vildagliptin—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Vildagliptin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Vildagliptin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Vildagliptin—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Vildagliptin—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Vildagliptin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Vildagliptin—Chills—Etoposide—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Vildagliptin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Vildagliptin—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Vildagliptin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Vildagliptin—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Vildagliptin—Oedema—Vincristine—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Vildagliptin—Infection—Vincristine—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Vildagliptin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Vildagliptin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Vildagliptin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Vildagliptin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00268	0.00268	CcSEcCtD
Vildagliptin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Vildagliptin—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Vildagliptin—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Vildagliptin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Vildagliptin—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Vildagliptin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Vildagliptin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Vildagliptin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Vildagliptin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Vildagliptin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Vildagliptin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Vildagliptin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Vildagliptin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Vildagliptin—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Vildagliptin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Vildagliptin—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Vildagliptin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Vildagliptin—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Vildagliptin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Vildagliptin—Headache—Topotecan—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Vildagliptin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Vildagliptin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Vildagliptin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Vildagliptin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Vildagliptin—Constipation—Vincristine—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Vildagliptin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Vildagliptin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Vildagliptin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Vildagliptin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Vildagliptin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Vildagliptin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Vildagliptin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Vildagliptin—Infection—Etoposide—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Vildagliptin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Vildagliptin—Nausea—Melphalan—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Vildagliptin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Vildagliptin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Vildagliptin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Vildagliptin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Vildagliptin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Vildagliptin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Vildagliptin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Vildagliptin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Vildagliptin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Vildagliptin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Vildagliptin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Vildagliptin—Constipation—Etoposide—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Vildagliptin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Vildagliptin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Vildagliptin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Vildagliptin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Vildagliptin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Vildagliptin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Vildagliptin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00175	0.00175	CcSEcCtD
Vildagliptin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Vildagliptin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Vildagliptin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Vildagliptin—Headache—Vincristine—peripheral nervous system neoplasm	0.00172	0.00172	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Vildagliptin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Vildagliptin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Vildagliptin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.00162	0.00162	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Vildagliptin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Vildagliptin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Vildagliptin—Chills—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Vildagliptin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Vildagliptin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Vildagliptin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Vildagliptin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Vildagliptin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Vildagliptin—Headache—Etoposide—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Vildagliptin—Nausea—Etoposide—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Vildagliptin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Vildagliptin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Vildagliptin—Infection—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Vildagliptin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Vildagliptin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Vildagliptin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Vildagliptin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Vildagliptin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Vildagliptin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000994	0.000994	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000993	0.000993	CcSEcCtD
Vildagliptin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000989	0.000989	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000985	0.000985	CcSEcCtD
Vildagliptin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Vildagliptin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000893	0.000893	CcSEcCtD
Vildagliptin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000852	0.000852	CcSEcCtD
Vildagliptin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000826	0.000826	CcSEcCtD
Vildagliptin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000823	0.000823	CcSEcCtD
Vildagliptin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Vildagliptin—Headache—Epirubicin—peripheral nervous system neoplasm	0.00078	0.00078	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000761	0.000761	CcSEcCtD
Vildagliptin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000739	0.000739	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000721	0.000721	CcSEcCtD
Vildagliptin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
